53 studies found for:    " September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
2 Completed Profile of HIV Seropositive Patients
Conditions: HIV Infection;   HIV Infections
Intervention:
3 Completed The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: Shang Ring circumcision
4 Completed Genotype Based Personalized Prescription of Nevirapine
Conditions: Nevirapine Induced Rash;   Nevirapine Induced Hepatitis;   HIV;   Adverse Side Effects;   AIDS;   HIV Infections
Interventions: Genetic: Genetic test for NVP induced rash;   Other: 3TC/D4T/NVP or 3TC/AZT/NVP
5 Active, not recruiting Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Conditions: Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: Placebo
6 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
7 Completed Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Conditions: HIV Prevention;   HIV Infections
Interventions: Drug: Tenofovir;   Drug: HEC Placebo;   Drug: Open label tenofovir tablet
8 Completed Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
9 Unknown  Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Drug: lopinavir/ritonavir plus maraviroc
10 Completed Europe-Africa Research Network for Evaluation of Second-line Therapy
Conditions: Human Immunodeficiency Virus;   HIV
Interventions: Drug: Aluvia + 2NRTIs;   Drug: Aluvia + raltegravir;   Drug: Aluvia monotherapy
11 Completed Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Condition: HIV Seropositive
Interventions: Drug: Rocaltrol;   Drug: Vitamin D;   Drug: Calcium
12 Completed QoL and Adherence to One-pill Once-a-day HAART
Conditions: HIV Infection;   HIV Infections
Intervention: Other: reduced number of pills
13 Completed
Has Results
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
14 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
15 Completed The Women's HIV SeroIncidence Study (ISIS)
Condition: HIV Infections
Intervention:
16 Active, not recruiting Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
Conditions: Parkinson's Disease;   HIV Infections
Intervention:
17 Completed HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Condition: HIV Infections
Intervention:
18 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
19 Unknown  Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
20 Completed Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX-B;   Biological: IL-12 DNA plasmids

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years